Literature DB >> 11891686

A combination of physical examination and ECG detects the majority of hemodynamically significant heart defects in neonates with Down syndrome.

Vandana Shashi1, Margaret N Berry, Wesley Covitz.   

Abstract

Echocardiography has become the method of choice in the diagnosis of a congenital heart defect (CHD) in neonates with Down syndrome. The most compelling argument for diagnosis of CHD in the neonatal period is the need for early surgical intervention (ideally prior to 6 months of age) in those with a complete atrioventricular (AV) canal. We evaluated the efficacy of a combined approach of physical examination (PE) and electrocardiography (ECG) in the detection of CHD in 49 neonates with Down syndrome. Our findings indicate that most hemodynamically significant defects (78%), especially a complete AV canal, can be detected by this approach. Hemodynamically insignificant minor defects, such as a small patent ductus arteriosus (PDA) and a small atrial septal defect (ASD), may be missed. Thus, echocardiography remains the most sensitive way to diagnose CHD. However, given that the combination of PE and ECG detects the majority of complete AV canal defects, it can be used as an alternative approach when echocardiography is not easily accessible, due to geographic or economic constraints. Follow-up after a few weeks of those with normal PE and ECG findings should enable detection of new symptoms and signs and evolving ECG findings that may have been missed in the immediate newborn period. Patients who are judged by PE and ECG to have CHD will need echocardiographic confirmation.

Entities:  

Mesh:

Year:  2002        PMID: 11891686     DOI: 10.1002/ajmg.10264

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  2 in total

1.  Screening for Congenital Heart Disease in Infants with Down Syndrome: Is Universal Echocardiography Necessary?

Authors:  Soujanya Bogarapu; Nelangi M Pinto; Susan P Etheridge; Xiaoming Sheng; Kirk N Liesemer; Paul C Young; Elizabeth V Saarel
Journal:  Pediatr Cardiol       Date:  2016-06-09       Impact factor: 1.655

2.  The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model.

Authors:  Matthieu Raveau; Jacques M Lignon; Valérie Nalesso; Arnaud Duchon; Yoram Groner; Andrew J Sharp; Doulaye Dembele; Véronique Brault; Yann Hérault
Journal:  PLoS Genet       Date:  2012-05-31       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.